TocopheRx raises $3.2 million in seed funding - MarketLine Financial Deals

TocopheRx raises $3.2 million in seed funding

TocopheRx raises $3.2 million in seed funding - MarketLine Financial Deals
TocopheRx raises $3.2 million in seed funding
Published Dec 02, 2013
2 pages — Published Dec 02, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

TocopheRx, a US-based developer of oral follicle-stimulating hormone (FSH) agonists for treatment of infertility, has secured $3.2 million in seed funding

  
Source:
Document ID
MA143587_131206
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "TocopheRx raises $3.2 million in seed funding" Dec 02, 2013. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/TocopheRx-raises-3-2-million-in-seed-funding-2052-99242>
  
APA:
MarketLine Financial Deals. (2013). TocopheRx raises $3.2 million in seed funding Dec 02, 2013. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/TocopheRx-raises-3-2-million-in-seed-funding-2052-99242>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.